No Data
New Analyst Coverage Sparks Interest in These 2 Stocks
Institutional Owners May Consider Drastic Measures as Radius Recycling, Inc.'s (NASDAQ:RDUS) Recent US$52m Drop Adds to Long-term Losses
Radius Recycling Publishes Fiscal Year 2024 Sustainability Report
Express News | Radius Pharmaceuticals Expands Abaloparatide Licensing Agreement With Theramex, Granting Exclusive Commercialization Rights For ELADYNOS In Mexico, Canada, South Africa, Israel, And Russia, Along With Additional Unpartnered Regions; Radius To Receive...
Radius Pharmaceuticals Expands Abaloparatide Licensing Agreement With Theramex Granting Additional Commercialization Rights Including Mexico, Canada, South Africa, Israel, and Russia
Steel Stocks Rise as Goldman Takes Positive View; Likes Cliffs, Commercial Metals, Nucor